Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial

Elizabeth C. Smyth, Samuel Rowley, Fay H. Cafferty, William Allum, Heike I. Grabsch, Sally Stenning, Andrew Wotherspoon, Derek Alderson, Tom Crosby, Was Mansoor, Justin S. Waters, Helen Neville-Webbe, Suzanne Darby, Jo Dent, Matthew Seymour, Joyce Thompson, Sharmila Sothi, Jane Blazeby, Ruth E. Langley, David Cunningham*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1181-1187
Number of pages7
JournalJAMA Oncology
Volume5
Issue number8
DOIs
Publication statusPublished - Aug 2019

Keywords

  • GASTRIC-CANCER
  • HER2
  • ESOPHAGEAL

Cite this